{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T12:22:40Z","timestamp":1773922960444,"version":"3.50.1"},"reference-count":45,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2013,4,26]],"date-time":"2013-04-26T00:00:00Z","timestamp":1366934400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Journal of Diabetes"],"published-print":{"date-parts":[[2013,6]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>The aim of the present study was to determine whether the administration of <jats:styled-content style=\"fixed-case\">D<\/jats:styled-content>iamel, marketed as a food supplement by <jats:styled-content style=\"fixed-case\">C<\/jats:styled-content>atalysis <jats:styled-content style=\"fixed-case\">L<\/jats:styled-content>aboratories (<jats:styled-content style=\"fixed-case\">M<\/jats:styled-content>adrid, <jats:styled-content style=\"fixed-case\">S<\/jats:styled-content>pain) could improve any of the components of metabolic syndrome (<jats:styled-content style=\"fixed-case\">MS<\/jats:styled-content>), as well as insulin resistance and sensitivity.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>In all, 100 patients with <jats:styled-content style=\"fixed-case\">MS<\/jats:styled-content> (19\u201370\u00a0years of age) who satisfied the <jats:styled-content style=\"fixed-case\">W<\/jats:styled-content>orld <jats:styled-content style=\"fixed-case\">H<\/jats:styled-content>ealth <jats:styled-content style=\"fixed-case\">O<\/jats:styled-content>rganization criteria for <jats:styled-content style=\"fixed-case\">MS<\/jats:styled-content> were included in the study. Participants were randomly assigned to receive either oral <jats:styled-content style=\"fixed-case\">D<\/jats:styled-content>iamel or a placebo (while maintaining a diet appropriate to their weight and physical activity) at a dose of two capsules before each of the three main meals each day for 1\u00a0year. Anthropometric indices, blood pressure, fasting plasma glucose, lipid profile, insulin, creatinine, and uric acid (<jats:styled-content style=\"fixed-case\">UA<\/jats:styled-content>) were determined. Insulin resistance (<jats:styled-content style=\"fixed-case\">IR<\/jats:styled-content>) was assessed and three indirect indices were used to calculate insulin sensitivity (<jats:styled-content style=\"fixed-case\">IS<\/jats:styled-content>).<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Compared with placebo, <jats:styled-content style=\"fixed-case\">D<\/jats:styled-content>iamel improved fasting insulin concentrations, <jats:styled-content style=\"fixed-case\">IS<\/jats:styled-content>, and <jats:styled-content style=\"fixed-case\">IR<\/jats:styled-content> and reduced <jats:styled-content style=\"fixed-case\">UA<\/jats:styled-content> concentrations from 6\u00a0months until the end of treatment (<jats:italic>P\u00a0<\/jats:italic>&lt;<jats:italic>\u00a0<\/jats:italic>0.05 for all). In addition, after 12\u00a0months treatment with <jats:styled-content style=\"fixed-case\">D<\/jats:styled-content>iamel, significant changes from baseline were seen for mean fasting insulin (<jats:italic>P\u00a0<\/jats:italic>&lt;<jats:italic>\u00a0<\/jats:italic>0.05), <jats:styled-content style=\"fixed-case\">UA<\/jats:styled-content> (<jats:italic>P\u00a0<\/jats:italic>&lt;<jats:italic>\u00a0<\/jats:italic>0.05), <jats:styled-content style=\"fixed-case\">IR<\/jats:styled-content> (<jats:italic>P\u00a0<\/jats:italic>&lt;<jats:italic>\u00a0<\/jats:italic>0.001), and <jats:styled-content style=\"fixed-case\">IS<\/jats:styled-content> (<jats:italic>P\u00a0<\/jats:italic>&lt;<jats:italic>\u00a0<\/jats:italic>0.001), whereas no such changes were seen in the placebo\u2010treated group. Improvements were noted in body mass index, <jats:styled-content style=\"fixed-case\">IR<\/jats:styled-content>, and <jats:styled-content style=\"fixed-case\">IS<\/jats:styled-content> in both groups.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Long\u2010term <jats:styled-content style=\"fixed-case\">D<\/jats:styled-content>iamel treatment, combined with lifestyle changes, was beneficial for <jats:styled-content style=\"fixed-case\">IR<\/jats:styled-content> and <jats:styled-content style=\"fixed-case\">IS<\/jats:styled-content>, and reduced serum <jats:styled-content style=\"fixed-case\">UA<\/jats:styled-content> levels in patients with <jats:styled-content style=\"fixed-case\">MS<\/jats:styled-content>.<\/jats:p><\/jats:sec>","DOI":"10.1111\/1753-0407.12007","type":"journal-article","created":{"date-parts":[[2012,9,17]],"date-time":"2012-09-17T10:35:09Z","timestamp":1347878109000},"page":"180-191","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Effect of <scp>D<\/scp>iamel in patients with metabolic syndrome: A randomized double\u2010blind placebo\u2010controlled study (Diamel\u5bf9\u4ee3\u8c22\u7efc\u5408\u5f81\u60a3\u8005\u7684\u5f71\u54cd\uff1a\u4e00\u9879\u968f\u673a\u53cc\u76f2\u5b89\u6170\u5242\u5bf9\u7167\u7814\u7a76)"],"prefix":"10.1111","volume":"5","author":[{"given":"Eduardo","family":"Cabrera\u2010Rode","sequence":"first","affiliation":[{"name":"National Institute of Endocrinology Havana Cuba"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Neraldo","family":"Orlandi","sequence":"additional","affiliation":[{"name":"National Institute of Endocrinology Havana Cuba"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yaneysi","family":"Padr\u00f3n","sequence":"additional","affiliation":[{"name":"National Institute of Endocrinology Havana Cuba"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Celeste","family":"Arranz","sequence":"additional","affiliation":[{"name":"National Institute of Endocrinology Havana Cuba"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raysa","family":"Olano","sequence":"additional","affiliation":[{"name":"National Institute of Endocrinology Havana Cuba"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mayra","family":"Machado","sequence":"additional","affiliation":[{"name":"National Institute of Endocrinology Havana Cuba"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arturo","family":"Hern\u00e1ndez\u2010Yero","sequence":"additional","affiliation":[{"name":"National Institute of Endocrinology Havana Cuba"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ra\u00fal","family":"Calder\u00edn","sequence":"additional","affiliation":[{"name":"Hermanos Amejeiras Hospital Havana Cuba"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emma","family":"Dom\u00ednguez","sequence":"additional","affiliation":[{"name":"National Institute of Endocrinology Havana Cuba"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2013,4,26]]},"reference":[{"key":"e_1_2_8_2_1","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.105.539528"},{"key":"e_1_2_8_3_1","doi-asserted-by":"publisher","DOI":"10.1097\/HCO.0b013e32833cd474"},{"key":"e_1_2_8_4_1","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S"},{"key":"e_1_2_8_5_1","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.epirev.a017978"},{"key":"e_1_2_8_6_1","doi-asserted-by":"publisher","DOI":"10.1093\/aje\/kwf145"},{"key":"e_1_2_8_7_1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-142-8-200504190-00009"},{"key":"e_1_2_8_8_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-005-0097-z"},{"key":"e_1_2_8_9_1","first-page":"31","article-title":"Tratamientos actuales y futuros del s\u00edndrome","volume":"51","author":"Standl E","year":"2006","journal-title":"Diabetes Voice"},{"key":"e_1_2_8_10_1","doi-asserted-by":"publisher","DOI":"10.4065\/83.8.932"},{"key":"e_1_2_8_11_1","doi-asserted-by":"publisher","DOI":"10.1517\/14656566.2011.585462"},{"key":"e_1_2_8_12_1","unstructured":"ChetaD TrifanEClinical study regarding the utilization of the preparation Diamel\u00aein the treatment of diabetes mellitus.2012. Available at:http:\/\/www.advancedalternativescenter.com\/Diabetes_s\/121.htm(accessed 28 September 2012)."},{"key":"e_1_2_8_13_1","first-page":"284","article-title":"Utilidad del diamel en pacientes con diabetes mellitus tipo 2 en tratamiento combinado con glibenclamida","volume":"23","author":"Hern\u00e1ndez Yero A","year":"2006","journal-title":"Av Diabetol"},{"key":"e_1_2_8_14_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1755-5922.2010.00218.x"},{"key":"e_1_2_8_15_1","first-page":"13","article-title":"Molecular mechanisms associating oxidative stress with endothelial dysfunction in the development of various vascular complications in diabetes mellitus","volume":"49","author":"Bekvarova GY","year":"2007","journal-title":"Folia Med"},{"key":"e_1_2_8_16_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF00280883"},{"key":"e_1_2_8_17_1","first-page":"1","article-title":"Reference criteria for insulin secretion indicators and of the lipid parameters in a hospital mixed population","volume":"21","author":"Arranz C","year":"2010","journal-title":"Rev Cubana Endocrinol"},{"key":"e_1_2_8_18_1","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S"},{"key":"e_1_2_8_19_1","doi-asserted-by":"publisher","DOI":"10.1177\/1099800406298775"},{"key":"e_1_2_8_20_1","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.22.6.1003"},{"key":"e_1_2_8_21_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1742-1241.2008.01965.x"},{"key":"e_1_2_8_22_1","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2458-9-276"},{"key":"e_1_2_8_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.annepidem.2009.06.010"},{"key":"e_1_2_8_24_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF00400196"},{"key":"e_1_2_8_25_1","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.20.4.537"},{"key":"e_1_2_8_26_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200105033441801"},{"key":"e_1_2_8_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(09)61706-2"},{"key":"e_1_2_8_28_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1463-1326.2012.01615.x"},{"key":"e_1_2_8_29_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00394-011-0284-2"},{"key":"e_1_2_8_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.freeradbiomed.2009.03.014"},{"key":"e_1_2_8_31_1","doi-asserted-by":"publisher","DOI":"10.1139\/y11-086"},{"key":"e_1_2_8_32_1","doi-asserted-by":"publisher","DOI":"10.14310\/horm.2002.1244"},{"key":"e_1_2_8_33_1","doi-asserted-by":"publisher","DOI":"10.3945\/jn.110.125336"},{"key":"e_1_2_8_34_1","doi-asserted-by":"publisher","DOI":"10.1021\/jf203488k"},{"key":"e_1_2_8_35_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.numecd.2007.05.002"},{"key":"e_1_2_8_36_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra0800885"},{"key":"e_1_2_8_37_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11906-010-0098-2"},{"key":"e_1_2_8_38_1","doi-asserted-by":"publisher","DOI":"10.3109\/10641960903265220"},{"key":"e_1_2_8_39_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00592-010-0231-3"},{"key":"e_1_2_8_40_1","first-page":"658","article-title":"Association between serum uric acid and early kidney damage in middle\u2010aged and elderly","volume":"90","author":"He S","year":"2010","journal-title":"Zhonghua Yi Xue Za Zhi"},{"key":"e_1_2_8_41_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2010.03.027"},{"key":"e_1_2_8_42_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa012512"},{"key":"e_1_2_8_43_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(02)08905-5"},{"key":"e_1_2_8_44_1","doi-asserted-by":"publisher","DOI":"10.2165\/00044011-200525100-00004"},{"key":"e_1_2_8_45_1","doi-asserted-by":"publisher","DOI":"10.1517\/14656566.8.18.3147"},{"key":"e_1_2_8_46_1","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/382719"}],"container-title":["Journal of Diabetes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2F1753-0407.12007","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/1753-0407.12007","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,15]],"date-time":"2023-10-15T17:19:28Z","timestamp":1697390368000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/1753-0407.12007"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,4,26]]},"references-count":45,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,6]]}},"alternative-id":["10.1111\/1753-0407.12007"],"URL":"https:\/\/doi.org\/10.1111\/1753-0407.12007","archive":["Portico"],"relation":{},"ISSN":["1753-0393","1753-0407"],"issn-type":[{"value":"1753-0393","type":"print"},{"value":"1753-0407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,4,26]]},"assertion":[{"value":"2012-03-25","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2012-09-11","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2013-04-26","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}